We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$847M
AUM Growth
+$73.3M
Cap. Flow
+$24.4M
Cap. Flow %
2.88%
Top 10 Hldgs %
61.2%
Holding
102
New
12
Increased
20
Reduced
2
Closed
1
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
2.1 years

Top Buys

Rank Stock Value
1
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$4.8M
2
AGN
Allergan plc
AGN
+$3.43M
3
ESRX
Express Scripts Holding Company
ESRX
+$2.3M
4
CELG
Celgene Corp
CELG
+$1.64M
5
GE icon
GE Aerospace
GE
+$1.5M

Top Sells

Rank Stock Value
1
OCRX
Ocera Therapeutics, Inc.
OCRX
+$771K
2
BMY icon
Bristol-Myers Squibb
BMY
+$450K

Sector Composition

Rank Sector Weight
1 Financials 39.48%
2 Healthcare 25.06%
3 Industrials 10.63%
4 Technology 10.11%
5 Materials 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SRPT icon
51
Sarepta Therapeutics
SRPT
$1.81B
$1.39M 0.16%
25,000
– –
2017 Q3
1 quarter
GE icon
52
GE Aerospace
GE
$326B
$1.31M 0.15%
+15,691
New +$1.5M
2017 Q4
0 quarters
TGTX icon
53
TG Therapeutics
TGTX
$8.26B
$1.31M 0.15%
160,000
– –
2017 Q1
3 quarters
ACAD icon
54
Acadia Pharmaceuticals
ACAD
$3.29B
$1.2M 0.14%
40,000
– –
2016 Q4
4 quarters
PGNX
55
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.19M 0.14%
200,000
– –
2017 Q3
1 quarter
BUD icon
56
AB InBev
BUD
$163B
$1.13M 0.13%
10,100
– –
2015 Q3
9 quarters
AMAG
57
DELISTED
AMAG Pharmaceuticals
AMAG
$1.06M 0.13%
80,000
+10,000
+14% +$151K
2017 Q1
3 quarters
ADMS
58
DELISTED
Adamas Pharmaceuticals
ADMS
$1.02M 0.12%
30,000
– –
2017 Q3
1 quarter
STOR
59
DELISTED
STORE Capital Corporation
STOR
$956K 0.11%
36,700
– –
2017 Q3
1 quarter
ALDX icon
60
Aldeyra Therapeutics
ALDX
$42.2M
$733K 0.09%
107,858
– –
2017 Q1
3 quarters
SYNT
61
DELISTED
Syntel Inc
SYNT
$719K 0.08%
31,270
– –
2017 Q1
3 quarters
AKTX icon
62
Akari Therapeutics
AKTX
$18.7M
$655K 0.08%
189
– –
2017 Q2
2 quarters
AKAO
63
DELISTED
Achaogen Inc
AKAO
$644K 0.08%
60,000
+30,000
+100% +$377K
2017 Q3
1 quarter
DNOW icon
64
DNOW Inc
DNOW
$2.83B
$614K 0.07%
55,675
– –
2014 Q2
14 quarters
BIVV
65
DELISTED
Bioverativ Inc. Common Stock
BIVV
$593K 0.07%
11,000
– –
2017 Q1
3 quarters
VWO icon
66
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$505K 0.06%
11,000
– –
2017 Q2
2 quarters
L icon
67
Loews
L
$22.6B
$485K 0.06%
9,700
– –
2017 Q2
2 quarters
SIOX
68
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$377K 0.04%
+8,951
New +$402K
2017 Q4
0 quarters
OCUL icon
69
Ocular Therapeutix
OCUL
$1.51B
$356K 0.04%
+80,011
New +$409K
2017 Q4
0 quarters
CPRI icon
70
Capri Holdings
CPRI
$1.81B
$331K 0.04%
5,260
– –
2017 Q3
1 quarter
NVR icon
71
NVR
NVR
$15.8B
$316K 0.04%
90
– –
2017 Q2
2 quarters
OMC icon
72
Omnicom Group
OMC
$22.1B
$306K 0.04%
+4,200
New +$301K
2017 Q4
0 quarters
ECL icon
73
Ecolab
ECL
$81B
$282K 0.03%
2,100
– –
2017 Q2
2 quarters
UI icon
74
Ubiquiti
UI
$36.4B
$281K 0.03%
3,950
– –
2017 Q2
2 quarters
BBY icon
75
Best Buy
BBY
$19.4B
$278K 0.03%
4,060
– –
2017 Q2
2 quarters
1 2
3
4

Similar funds

TPW
Talon Private Wealth The Villages, Florida $855M AUM
EWA
Evolution Wealth Advisors Aventura, Florida $855M AUM 27.24% 1-Year Est. Return
DCM
Dimension Capital Management Coral Gables, Florida $854M AUM 21.01% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $853M AUM 15.61% 1-Year Est. Return
QIM
Quest Investment Management Lake Oswego, Oregon $856M AUM 29.41% 1-Year Est. Return
AIMC
Alley Investment Management Company Lake Forest, Illinois $856M AUM 15.11% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $853M AUM 18.22% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return

Hikari Power's Q4 2017 Portfolio in Review

As of Q4 2017, Hikari Power held 102 positions worth $847M, up 9.5% from $774M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power's Q4 2017 filing shows 12 new, 20 increased, 2 reduced and 1 closed positions. Its largest new stake was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares): 129,200 shares worth $5.21M. The largest sale was Ocera Therapeutics, Inc., an estimated $771K.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q4 2017 buy was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares): 129,200 shares worth $5.21M.
  • Hikari Power added most to Allergan plc in Q4 2017, an estimated $3.43M increase.
  • Hikari Power's biggest Q4 2017 reduction was Bristol-Myers Squibb, cutting an estimated $450K.
  • Hikari Power fully exited Ocera Therapeutics, Inc. in Q4 2017, selling an estimated $771K.
  • Hikari Power's ten largest holdings make up 61% of its $847M portfolio in Q4 2017.
  • Hikari Power opened 12 new positions and closed 1 in Q4 2017.
  • Hikari Power's portfolio value rose 9.5% quarter-over-quarter to $847M.

Based on Hikari Power's 13F filing for Q4 2017, filed 12 Jan 2018.